Rothschild & Co Asset Management US’s AdaptHealth AHCO Stock Holding History

Rothschild & Co Asset Management US’s Portfolio AHCO Stock Details AHCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$11.9M	Sell	620,566 -4,967	-0.8%	-$105K	0.18%	93
2022 Q3	$11.7M	Sell	625,533 -11,545	-2%	-$237K	0.2%	93
2022 Q2	$11.5M	Sell	637,078 -12,639	-2%	-$205K	0.18%	106
2022 Q1	$10.4M	Sell	649,717 -207,585	-24%	-$3.73M	0.13%	135
2021 Q4	$21M	Sell	857,302 -25,956	-3%	-$609K	0.25%	109
2021 Q3	$20.6M	Buy	883,258 +86,143	+11%	+$2.08M	0.26%	105
2021 Q2	$21.8M	Buy	797,115 +199,135	+33%	+$5.68M	0.26%	118
2021 Q1	$22M	Sell	597,980 -83,848	-12%	-$2.96M	0.27%	116
2020 Q4	$25.6M	Buy	+681,828	New	+$21.1M	0.33%	98

Other funds holding AHCO

OCA

OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SkyKnight Capital San Francisco, California $107M AUM 9.69% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Rothschild & Co Asset Management US's AHCO Position: Q4 2022 in Review

Rothschild & Co Asset Management US reduced its AdaptHealth (AHCO) stake by 0.79% in Q4 2022, selling an estimated $105K and leaving 620,566 shares worth $11.9M. The position accounts for 0.18% of the portfolio, ranked #93.

Rothschild & Co Asset Management US first reported a position in AHCO in Q4 2020 and has held it in 9 quarters since. The position peaked at $25.6M in Q4 2020. 193 funds tracked by Wall St. Rank hold AHCO as of Q4 2022.

Rothschild & Co Asset Management US held 620,566 shares of AdaptHealth worth $11.9M as of Q4 2022.
Rothschild & Co Asset Management US sold 4,967 AdaptHealth shares in Q4 2022, an estimated $105K.
AdaptHealth made up 0.18% of Rothschild & Co Asset Management US's portfolio in Q4 2022, its #93 holding.
Rothschild & Co Asset Management US first reported a position in AdaptHealth in Q4 2020 and has held it in 9 quarters since.
Rothschild & Co Asset Management US's AdaptHealth position peaked at $25.6M in Q4 2020.
193 funds tracked by Wall St. Rank held AdaptHealth as of Q4 2022.

Based on Rothschild & Co Asset Management US's 13F filing for Q4 2022, filed 14 Feb 2023.